FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37228011000001102: Dacomitinib 15mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
245991000001116 Dacomitinib 15mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
246001000001117 Dacomitinib 15mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dacomitinib 15mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has VMP Dacomitinib 15mg tablets true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has specific active ingredient Dacomitinib monohydrate false Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dacomitinib false Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has specific active ingredient Dacomitinib monohydrate true Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dacomitinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vizimpro 15mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is a True Dacomitinib 15mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start